Lisanti Capital Growth’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
Sell
-1,198
Closed -$435K 105
2013
Q4
$435K Buy
+1,198
New +$435K 0.18% 105